Vancomycin-Induced Nephrotoxicity Guidelines

Introduction to Nephrotoxicity Risk

The American College of Cardiology and other guideline societies recommend monitoring vancomycin trough levels to minimize nephrotoxicity risk, as sustained trough concentrations >20 μg/mL significantly amplify nephrotoxicity risk, even in patients with normal baseline renal function 1

Nephrotoxicity manifests as multiple increases in serum creatinine of ≥0.5 mg/dL or a 150% increase from baseline, typically occurring after several days of therapy, and the American College of Clinical Pharmacy recommends monitoring serum creatinine at least twice weekly throughout therapy 1
The American Society of Health-System Pharmacists recommends target trough levels of 15-20 mg/L for serious infections, as levels above this range exponentially increase nephrotoxicity without improving efficacy 4, 1

Concurrent nephrotoxic medications, particularly aminoglycosides and loop diuretics, dramatically increase nephrotoxicity risk through additive tubular injury mechanisms, according to the American Heart Association 2, 3

The American College of Clinical Pharmacy recommends never combining vancomycin with aminoglycosides without compelling indication, as this combination carries substantially higher nephrotoxicity and ototoxicity risk than either agent alone 2, 3
The Infectious Diseases Society of America recommends never relying on standard nomograms in patients developing renal impairment, as these were not designed for therapeutic targets and will cause overdosing 4